Scholarlink

Background <p>Sarcoidosis is a complex multisystemic disease with a wide range of clinical manifestations. Its severity and evolution are highly variable and the prognostic utility of paraclinical markers is debated. We analysed the utility of the CD4/CD8 T-cell ratio (R) in bronchoalveolar lavage (BAL) fluid as a marker of sarcoidosis severity.</p> Methods <p>We conducted an observational, retrospective, monocentric study involving patients with systemic sarcoidosis who underwent BAL for diagnostic purposes between June 2010 and April 2020.</p> Results <p>Among 62 patients, half had a CD4/CD8 T-cell ratio (<i>R</i>) value ≥ 3.5. Patients with <i>R</i> &lt; 3.5 had more extrapulmonary manifestations, mainly abdominal (32.3% vs. 6.5%, <i>p</i> = 0.01) and tended to have a higher frequency of cardiac/central nervous system involvement (19.4% vs. 6.5%, <i>p</i> = 0.25). They also had more frequent interstitial lung involvement (80.6% vs. 67.7%, <i>p</i> = 0.2) and tended to have more severe respiratory impairment. The activation (<i>p</i> = 0.01) of CD8 + T cells in peripheral blood was significantly higher in patients with <i>R</i> &lt; 3.5. By contrast, patients with <i>R</i> ≥ 3.5 tended to have more frequent musculoskeletal–cutaneous involvement (48.4% vs. 32.3%, <i>p</i> = 0.2). Treatment was initiated more frequently in patients with <i>R</i> &lt; 3.5 (71% vs. 35.5%, <i>p</i> = 0.01), who also more frequently required immunosuppressive agents (54.5% vs. 36.4%, <i>p</i> = 0.02).</p> Conclusion <p>An <i>R</i> value &lt; 3.5 in BAL fluid has potential as a marker of sarcoidosis severity. Patients with a low <i>R</i> value had a worse prognosis with more severe respiratory impairment and more frequent multisystemic and extra-pulmonary involvement, and more frequently required immunosuppressive agents.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

CD4/CD8 T-cell ratio in bronchoalveolar lavage fluid as a marker of sarcoidosis severity: a retrospective study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月9日

查看全文
  • Thibaut Zannese,
  • Jean-François Viallard,
  • Soumaya Sridi-Cheniti,
  • Camille Prot-Leurent,
  • Henry Dupuy,
  • Cédric Léonard,
  • Pierre Duffau,
  • Estibaliz Lazaro,
  • Carine Greib,
  • Etienne Rivière

摘要

Background

Sarcoidosis is a complex multisystemic disease with a wide range of clinical manifestations. Its severity and evolution are highly variable and the prognostic utility of paraclinical markers is debated. We analysed the utility of the CD4/CD8 T-cell ratio (R) in bronchoalveolar lavage (BAL) fluid as a marker of sarcoidosis severity.

Methods

We conducted an observational, retrospective, monocentric study involving patients with systemic sarcoidosis who underwent BAL for diagnostic purposes between June 2010 and April 2020.

Results

Among 62 patients, half had a CD4/CD8 T-cell ratio (R) value ≥ 3.5. Patients with R < 3.5 had more extrapulmonary manifestations, mainly abdominal (32.3% vs. 6.5%, p = 0.01) and tended to have a higher frequency of cardiac/central nervous system involvement (19.4% vs. 6.5%, p = 0.25). They also had more frequent interstitial lung involvement (80.6% vs. 67.7%, p = 0.2) and tended to have more severe respiratory impairment. The activation (p = 0.01) of CD8 + T cells in peripheral blood was significantly higher in patients with R < 3.5. By contrast, patients with R ≥ 3.5 tended to have more frequent musculoskeletal–cutaneous involvement (48.4% vs. 32.3%, p = 0.2). Treatment was initiated more frequently in patients with R < 3.5 (71% vs. 35.5%, p = 0.01), who also more frequently required immunosuppressive agents (54.5% vs. 36.4%, p = 0.02).

Conclusion

An R value < 3.5 in BAL fluid has potential as a marker of sarcoidosis severity. Patients with a low R value had a worse prognosis with more severe respiratory impairment and more frequent multisystemic and extra-pulmonary involvement, and more frequently required immunosuppressive agents.